🚨BREAKING: xAI in talks to raise $4.3B in equity funding via Bloomberg https://t.co/00YWh4X49S ...

DOVER, Del., June 09, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”) announce that on June 5, 2025 Portage and Compedica Holdings Limited, a company formed under the laws of the Isle of Man (“Compedica”) entered a mutual Subscription Agreement (“Subscription Agreement”). Pursuant to the Subscription Agreement, Portage issued 625,000 ordinary shares at a per share price of $8.00 in exchange ...

Core Viewpoint - FOXO Technologies Inc. has executed an agreement to issue 1,650 shares of Series A Cumulative Convertible Redeemable Preferred Stock for net proceeds of $1,500,000, indicating a strategic move to enhance its financial position and support growth initiatives [1][2]. Financial Summary - The issuance of Series A Preferred Stock is expected to generate gross proceeds of $1,650,000, with the company agreeing to pay investor costs of $150,000 [2]. - The first closing of this transaction occurred on June 4, 2025, with subsequent closings planned based on the effective date of a registration statement [2]. - In the first quarter of 2025, FOXO reported over $3 million in net revenues and a $4.4 million improvement in stockholders' equity, bringing total stockholders' equity to $9.7 million as of March 31, 2025, compared to a negative $17.5 million as of September 30, 2024 [3]. Company Overview - FOXO Technologies operates three subsidiaries: Rennova Community Health, which runs a critical access hospital in East Tennessee; Myrtle Recovery Centers, a behavioral health facility; and FOXO Labs, a biotechnology company focused on health and lifespan improvement through innovative technology [4][5].